287 related articles for article (PubMed ID: 28082868)
1. Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase.
Campanari ML; García-Ayllón MS; Ciura S; Sáez-Valero J; Kabashi E
Front Mol Neurosci; 2016; 9():160. PubMed ID: 28082868
[TBL] [Abstract][Full Text] [Related]
2. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease.
Moloney EB; de Winter F; Verhaagen J
Front Neurosci; 2014; 8():252. PubMed ID: 25177267
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.
Verma S; Khurana S; Vats A; Sahu B; Ganguly NK; Chakraborti P; Gourie-Devi M; Taneja V
Mol Neurobiol; 2022 Mar; 59(3):1502-1527. PubMed ID: 34997540
[TBL] [Abstract][Full Text] [Related]
4. Targeting acetylcholinesterase to the neuromuscular synapse.
Rotundo RL; Rossi SG; Kimbell LM; Ruiz C; Marrero E
Chem Biol Interact; 2005 Dec; 157-158():15-21. PubMed ID: 16289417
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish.
Campanari ML; Marian A; Ciura S; Kabashi E
Cells; 2021 Jan; 10(2):. PubMed ID: 33499374
[TBL] [Abstract][Full Text] [Related]
6. Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.
Ito M; Suzuki Y; Okada T; Fukudome T; Yoshimura T; Masuda A; Takeda S; Krejci E; Ohno K
Mol Ther; 2012 Jul; 20(7):1384-92. PubMed ID: 22371845
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
[TBL] [Abstract][Full Text] [Related]
8. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
[TBL] [Abstract][Full Text] [Related]
10. Developmental consequences of the ColQ/MuSK interactions.
Karmouch J; Dobbertin A; Sigoillot S; Legay C
Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
[TBL] [Abstract][Full Text] [Related]
11. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase and agrin: different functions, similar expression patterns, multiple roles.
Mis K; Matkovic U; Pirkmajer S; Sciancalepore M; Lorenzon P; Mars T; Grubic Z
Chem Biol Interact; 2013 Mar; 203(1):297-301. PubMed ID: 23117006
[TBL] [Abstract][Full Text] [Related]
13. Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice.
Just-Borràs L; Hurtado E; Cilleros-Mañé V; Biondi O; Charbonnier F; Tomàs M; Garcia N; Lanuza MA; Tomàs J
Mol Neurobiol; 2019 Oct; 56(10):6856-6872. PubMed ID: 30929165
[TBL] [Abstract][Full Text] [Related]
14. Expression and distribution of acetylcholinesterase among the cellular components of the neuromuscular junction formed in human myotube in vitro.
Mis K; Mars T; Jevsek M; Strasek H; Golicnik M; Brecelj J; Komel R; King MP; Miranda AF; Grubic Z
Chem Biol Interact; 2005 Dec; 157-158():29-35. PubMed ID: 16256091
[TBL] [Abstract][Full Text] [Related]
15. The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis.
Pikatza-Menoio O; Elicegui A; Bengoetxea X; Naldaiz-Gastesi N; López de Munain A; Gerenu G; Gil-Bea FJ; Alonso-Martín S
J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357138
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterases regulation in the absence of ColQ.
Sigoillot SM; Bourgeois F; Legay C
Chem Biol Interact; 2010 Sep; 187(1-3):84-9. PubMed ID: 20153305
[TBL] [Abstract][Full Text] [Related]
17. The NMJ as a model synapse: New perspectives on formation, synaptic transmission and maintenance: Acetylcholinesterase at the neuromuscular junction.
Rotundo RL
Neurosci Lett; 2020 Sep; 735():135157. PubMed ID: 32540360
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of acetylcholinesterase at the neuromuscular junction.
Rotundo RL
J Neurocytol; 2003; 32(5-8):743-66. PubMed ID: 15034265
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function.
Feng G; Krejci E; Molgo J; Cunningham JM; Massoulié J; Sanes JR
J Cell Biol; 1999 Mar; 144(6):1349-60. PubMed ID: 10087275
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional organization of synaptic acetylcholinesterase.
Aldunate R; Casar JC; Brandan E; Inestrosa NC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):96-104. PubMed ID: 15572165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
